Effect of Vitamin D on Hormonal, Metabolic and Cardiovascular Risk Factors in Patients With Polycystic Ovary Syndrome

NCT02513381 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

Polycystic Ovary Syndrome

Interventions

OTHER: Vitamin D3, 3200IU
OTHER: Placebo

Sponsor

Hull University Teaching Hospitals NHS Trust

Collaborators

[object Object]